Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 4, 1996, Pages 583-586

  Bein, Thomas ^a   Metz, Christoph ^a   Keyl, Cornelius ^a   Sendtner, Ernst ^a   Pfeifer, Michael ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Acute pulmonary hypertension; Aerosolization; Prostacyclin; Respiratory failure

Indexed keywords

ARACHIDONIC ACID; PROSTACYCLIN;

ACUTE RESPIRATORY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT OUTCOME; VENTILATOR;

AEROSOLS; BLOOD PRESSURE; CARDIAC OUTPUT; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PULMONARY GAS EXCHANGE; PULMONARY WEDGE PRESSURE; RESPIRATORY INSUFFICIENCY; VASCULAR RESISTANCE;

EID: 0029881575     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199604000-00019     Document Type: Article

References (12)

1. Zapol WM, Snider MT. Pulmonary artery hypertension in severe acute respiratory failure. N Engl J Med 1977;296: 476-80.
2. Redl G, Germann P, Plattner H, Hammerle A. Right ventricular function in early septic shock states. Intensive Care Med 1992;19:3-7.
3. Moncada S, Vane RJ. Pharmacology and endogenous roles of prostaglandin endoeroxides, endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1979:30:293-331.
4. Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ. Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS. Intensive Care Med 1990;16:227-32.
5. Walmrath D, Schneider Th, Pilch J, Grimminger F, Seeger W. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993;342:961-2.
6. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 1993; 25:329-40.
7. Bein T, Pfeifer M, Riegger G, Taeger K. Continuous intraarterial measurement of oxygenation during aerosolized prostacyclin administration in severe respiratory failure. N Engl J Med 1994;331:335-6.
8. Murray JF, Matthay MA. Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Resp Dis 1988;138:720-3.
9. Palevsky HI, Long W, Crow J, Fishman AP. Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension. Circulation 1990;82:2018-26.
10. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol W. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
11. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W. Effects of aerosolized prostacyclin in severe pneumonia - impact of fibrosis. Am J Resp Crit Care Med 1995;151:724-30.
12. Zwissler B, Weite M, Messmer K. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth 1995;9:283-9.